nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRA2A—epilepsy syndrome	0.357	0.506	CbGaD
Dipivefrin—BCHE—epilepsy syndrome	0.348	0.494	CbGaD
Dipivefrin—Stinging—Propofol—epilepsy syndrome	0.00349	0.0405	CcSEcCtD
Dipivefrin—Mydriasis—Fosphenytoin—epilepsy syndrome	0.00331	0.0384	CcSEcCtD
Dipivefrin—Mydriasis—Diazepam—epilepsy syndrome	0.00318	0.0368	CcSEcCtD
Dipivefrin—Bambuterol—BCHE—epilepsy syndrome	0.00301	0.707	CrCbGaD
Dipivefrin—Mydriasis—Phenytoin—epilepsy syndrome	0.00288	0.0334	CcSEcCtD
Dipivefrin—Mydriasis—Oxcarbazepine—epilepsy syndrome	0.00287	0.0332	CcSEcCtD
Dipivefrin—Mydriasis—Carbamazepine—epilepsy syndrome	0.00275	0.0319	CcSEcCtD
Dipivefrin—Mydriasis—Pregabalin—epilepsy syndrome	0.00191	0.0221	CcSEcCtD
Dipivefrin—Conjunctivitis—Levetiracetam—epilepsy syndrome	0.00149	0.0172	CcSEcCtD
Dipivefrin—Mydriasis—Topiramate—epilepsy syndrome	0.00147	0.0171	CcSEcCtD
Dipivefrin—Conjunctivitis—Fosphenytoin—epilepsy syndrome	0.00144	0.0166	CcSEcCtD
Dipivefrin—Conjunctivitis—Vigabatrin—epilepsy syndrome	0.0014	0.0162	CcSEcCtD
Dipivefrin—Conjunctivitis—Diazepam—epilepsy syndrome	0.00138	0.016	CcSEcCtD
Dipivefrin—Hypersensitivity—Amobarbital—epilepsy syndrome	0.00134	0.0155	CcSEcCtD
Dipivefrin—Conjunctivitis—Felbamate—epilepsy syndrome	0.00133	0.0155	CcSEcCtD
Dipivefrin—Conjunctivitis—Zonisamide—epilepsy syndrome	0.00131	0.0151	CcSEcCtD
Dipivefrin—Arrhythmia—Propofol—epilepsy syndrome	0.00127	0.0147	CcSEcCtD
Dipivefrin—Conjunctivitis—Phenytoin—epilepsy syndrome	0.00125	0.0145	CcSEcCtD
Dipivefrin—ADRA1A—hindbrain—epilepsy syndrome	0.00122	0.0579	CbGeAlD
Dipivefrin—Conjunctivitis—Carbamazepine—epilepsy syndrome	0.00119	0.0138	CcSEcCtD
Dipivefrin—Pain—Phenobarbital—epilepsy syndrome	0.00117	0.0135	CcSEcCtD
Dipivefrin—Conjunctivitis—Lamotrigine—epilepsy syndrome	0.00115	0.0134	CcSEcCtD
Dipivefrin—Arrhythmia—Diazepam—epilepsy syndrome	0.00114	0.0132	CcSEcCtD
Dipivefrin—ACHE—telencephalon—epilepsy syndrome	0.00112	0.0532	CbGeAlD
Dipivefrin—Hypertension—Propofol—epilepsy syndrome	0.00107	0.0124	CcSEcCtD
Dipivefrin—Arrhythmia—Oxcarbazepine—epilepsy syndrome	0.00103	0.0119	CcSEcCtD
Dipivefrin—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.00101	0.0117	CcSEcCtD
Dipivefrin—Hypertension—Fosphenytoin—epilepsy syndrome	0.000996	0.0116	CcSEcCtD
Dipivefrin—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000987	0.0114	CcSEcCtD
Dipivefrin—Tachycardia—Propofol—epilepsy syndrome	0.000986	0.0114	CcSEcCtD
Dipivefrin—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000984	0.0114	CcSEcCtD
Dipivefrin—Tachycardia—Midazolam—epilepsy syndrome	0.000965	0.0112	CcSEcCtD
Dipivefrin—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000926	0.0107	CcSEcCtD
Dipivefrin—Hypertension—Felbamate—epilepsy syndrome	0.000926	0.0107	CcSEcCtD
Dipivefrin—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000919	0.0107	CcSEcCtD
Dipivefrin—Conjunctivitis—Valproic Acid—epilepsy syndrome	0.000916	0.0106	CcSEcCtD
Dipivefrin—Hypertension—Zonisamide—epilepsy syndrome	0.000906	0.0105	CcSEcCtD
Dipivefrin—ACHE—medulla oblongata—epilepsy syndrome	0.000883	0.0418	CbGeAlD
Dipivefrin—Tachycardia—Diazepam—epilepsy syndrome	0.000882	0.0102	CcSEcCtD
Dipivefrin—Hypertension—Phenytoin—epilepsy syndrome	0.000867	0.0101	CcSEcCtD
Dipivefrin—Pain—Propofol—epilepsy syndrome	0.000864	0.01	CcSEcCtD
Dipivefrin—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000863	0.01	CcSEcCtD
Dipivefrin—Tachycardia—Felbamate—epilepsy syndrome	0.000854	0.0099	CcSEcCtD
Dipivefrin—Pain—Midazolam—epilepsy syndrome	0.000845	0.0098	CcSEcCtD
Dipivefrin—Tachycardia—Zonisamide—epilepsy syndrome	0.000836	0.00969	CcSEcCtD
Dipivefrin—Pain—Levetiracetam—epilepsy syndrome	0.000835	0.00968	CcSEcCtD
Dipivefrin—Conjunctivitis—Pregabalin—epilepsy syndrome	0.000828	0.0096	CcSEcCtD
Dipivefrin—Hypertension—Carbamazepine—epilepsy syndrome	0.000828	0.0096	CcSEcCtD
Dipivefrin—ACHE—midbrain—epilepsy syndrome	0.000807	0.0382	CbGeAlD
Dipivefrin—Tachycardia—Clonazepam—epilepsy syndrome	0.000806	0.00934	CcSEcCtD
Dipivefrin—Tachycardia—Phenytoin—epilepsy syndrome	0.0008	0.00928	CcSEcCtD
Dipivefrin—Hypertension—Lamotrigine—epilepsy syndrome	0.0008	0.00928	CcSEcCtD
Dipivefrin—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000796	0.00923	CcSEcCtD
Dipivefrin—ACHE—spinal cord—epilepsy syndrome	0.000788	0.0373	CbGeAlD
Dipivefrin—Pain—Vigabatrin—epilepsy syndrome	0.000785	0.00911	CcSEcCtD
Dipivefrin—Pain—Diazepam—epilepsy syndrome	0.000773	0.00896	CcSEcCtD
Dipivefrin—Tachycardia—Carbamazepine—epilepsy syndrome	0.000764	0.00886	CcSEcCtD
Dipivefrin—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000759	0.00881	CcSEcCtD
Dipivefrin—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000756	0.00876	CcSEcCtD
Dipivefrin—Pain—Felbamate—epilepsy syndrome	0.000748	0.00868	CcSEcCtD
Dipivefrin—Tachycardia—Lamotrigine—epilepsy syndrome	0.000738	0.00856	CcSEcCtD
Dipivefrin—Hypersensitivity—Midazolam—epilepsy syndrome	0.000728	0.00844	CcSEcCtD
Dipivefrin—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000719	0.00834	CcSEcCtD
Dipivefrin—Pain—Clonazepam—epilepsy syndrome	0.000706	0.00818	CcSEcCtD
Dipivefrin—ADRA1A—brainstem—epilepsy syndrome	0.0007	0.0332	CbGeAlD
Dipivefrin—Pain—Oxcarbazepine—epilepsy syndrome	0.000697	0.00809	CcSEcCtD
Dipivefrin—Arrhythmia—Pregabalin—epilepsy syndrome	0.000683	0.00792	CcSEcCtD
Dipivefrin—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000676	0.00784	CcSEcCtD
Dipivefrin—ADRA1A—forebrain—epilepsy syndrome	0.000676	0.032	CbGeAlD
Dipivefrin—Pain—Carbamazepine—epilepsy syndrome	0.000669	0.00776	CcSEcCtD
Dipivefrin—Hypersensitivity—Diazepam—epilepsy syndrome	0.000666	0.00772	CcSEcCtD
Dipivefrin—Pain—Lamotrigine—epilepsy syndrome	0.000647	0.0075	CcSEcCtD
Dipivefrin—Epinephrine—ADRA2A—epilepsy syndrome	0.000639	0.15	CrCbGaD
Dipivefrin—Conjunctivitis—Topiramate—epilepsy syndrome	0.000639	0.00741	CcSEcCtD
Dipivefrin—Hypertension—Valproic Acid—epilepsy syndrome	0.000636	0.00737	CcSEcCtD
Dipivefrin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000631	0.00732	CcSEcCtD
Dipivefrin—ACHE—cerebellum—epilepsy syndrome	0.000624	0.0296	CbGeAlD
Dipivefrin—BCHE—brainstem—epilepsy syndrome	0.000623	0.0295	CbGeAlD
Dipivefrin—ADRA1A—telencephalon—epilepsy syndrome	0.000621	0.0294	CbGeAlD
Dipivefrin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000608	0.00705	CcSEcCtD
Dipivefrin—Epinephrine—TNF—epilepsy syndrome	0.000606	0.142	CrCbGaD
Dipivefrin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000604	0.007	CcSEcCtD
Dipivefrin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000601	0.00697	CcSEcCtD
Dipivefrin—BCHE—forebrain—epilepsy syndrome	0.000601	0.0285	CbGeAlD
Dipivefrin—ADRA2C—telencephalon—epilepsy syndrome	0.000592	0.028	CbGeAlD
Dipivefrin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000587	0.0068	CcSEcCtD
Dipivefrin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000577	0.00669	CcSEcCtD
Dipivefrin—Hypertension—Pregabalin—epilepsy syndrome	0.000575	0.00667	CcSEcCtD
Dipivefrin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000557	0.00646	CcSEcCtD
Dipivefrin—BCHE—telencephalon—epilepsy syndrome	0.000552	0.0262	CbGeAlD
Dipivefrin—Tachycardia—Pregabalin—epilepsy syndrome	0.00053	0.00615	CcSEcCtD
Dipivefrin—Hypertension—Gabapentin—epilepsy syndrome	0.000527	0.00611	CcSEcCtD
Dipivefrin—Pain—Valproic Acid—epilepsy syndrome	0.000514	0.00596	CcSEcCtD
Dipivefrin—ADRA2A—forebrain—epilepsy syndrome	0.000514	0.0243	CbGeAlD
Dipivefrin—ACHE—brain—epilepsy syndrome	0.000507	0.024	CbGeAlD
Dipivefrin—Tachycardia—Gabapentin—epilepsy syndrome	0.000486	0.00564	CcSEcCtD
Dipivefrin—ADRA2A—telencephalon—epilepsy syndrome	0.000473	0.0224	CbGeAlD
Dipivefrin—ADRA2C—medulla oblongata—epilepsy syndrome	0.000465	0.022	CbGeAlD
Dipivefrin—Pain—Pregabalin—epilepsy syndrome	0.000465	0.00539	CcSEcCtD
Dipivefrin—Hypertension—Topiramate—epilepsy syndrome	0.000443	0.00514	CcSEcCtD
Dipivefrin—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000443	0.00513	CcSEcCtD
Dipivefrin—BCHE—medulla oblongata—epilepsy syndrome	0.000434	0.0206	CbGeAlD
Dipivefrin—Pain—Gabapentin—epilepsy syndrome	0.000426	0.00494	CcSEcCtD
Dipivefrin—ADRA2C—midbrain—epilepsy syndrome	0.000425	0.0201	CbGeAlD
Dipivefrin—ADRA2C—spinal cord—epilepsy syndrome	0.000415	0.0197	CbGeAlD
Dipivefrin—Tachycardia—Topiramate—epilepsy syndrome	0.000409	0.00474	CcSEcCtD
Dipivefrin—Hypersensitivity—Pregabalin—epilepsy syndrome	0.0004	0.00464	CcSEcCtD
Dipivefrin—BCHE—midbrain—epilepsy syndrome	0.000397	0.0188	CbGeAlD
Dipivefrin—BCHE—spinal cord—epilepsy syndrome	0.000387	0.0183	CbGeAlD
Dipivefrin—ADRA1A—head—epilepsy syndrome	0.000387	0.0183	CbGeAlD
Dipivefrin—ADRA2A—medulla oblongata—epilepsy syndrome	0.000371	0.0176	CbGeAlD
Dipivefrin—ADRA2C—head—epilepsy syndrome	0.000369	0.0175	CbGeAlD
Dipivefrin—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000367	0.00426	CcSEcCtD
Dipivefrin—ADRA1A—nervous system—epilepsy syndrome	0.000367	0.0174	CbGeAlD
Dipivefrin—Pain—Topiramate—epilepsy syndrome	0.000358	0.00416	CcSEcCtD
Dipivefrin—ADRA1A—central nervous system—epilepsy syndrome	0.000353	0.0167	CbGeAlD
Dipivefrin—ADRA2C—nervous system—epilepsy syndrome	0.00035	0.0166	CbGeAlD
Dipivefrin—ADRA1A—cerebellum—epilepsy syndrome	0.000345	0.0164	CbGeAlD
Dipivefrin—BCHE—head—epilepsy syndrome	0.000344	0.0163	CbGeAlD
Dipivefrin—ADRA2A—midbrain—epilepsy syndrome	0.000339	0.0161	CbGeAlD
Dipivefrin—ADRA2C—central nervous system—epilepsy syndrome	0.000337	0.0159	CbGeAlD
Dipivefrin—ADRA2A—spinal cord—epilepsy syndrome	0.000331	0.0157	CbGeAlD
Dipivefrin—ADRA2C—cerebellum—epilepsy syndrome	0.000329	0.0156	CbGeAlD
Dipivefrin—BCHE—nervous system—epilepsy syndrome	0.000326	0.0154	CbGeAlD
Dipivefrin—BCHE—central nervous system—epilepsy syndrome	0.000314	0.0149	CbGeAlD
Dipivefrin—Hypersensitivity—Topiramate—epilepsy syndrome	0.000309	0.00358	CcSEcCtD
Dipivefrin—BCHE—cerebellum—epilepsy syndrome	0.000307	0.0145	CbGeAlD
Dipivefrin—ADRA2A—head—epilepsy syndrome	0.000294	0.0139	CbGeAlD
Dipivefrin—ADRA1A—brain—epilepsy syndrome	0.00028	0.0133	CbGeAlD
Dipivefrin—ADRA2A—nervous system—epilepsy syndrome	0.000279	0.0132	CbGeAlD
Dipivefrin—ADRA2A—central nervous system—epilepsy syndrome	0.000269	0.0127	CbGeAlD
Dipivefrin—ADRA2C—brain—epilepsy syndrome	0.000267	0.0127	CbGeAlD
Dipivefrin—ADRA2A—cerebellum—epilepsy syndrome	0.000263	0.0124	CbGeAlD
Dipivefrin—BCHE—brain—epilepsy syndrome	0.000249	0.0118	CbGeAlD
Dipivefrin—ADRA2A—brain—epilepsy syndrome	0.000213	0.0101	CbGeAlD
Dipivefrin—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.07e-05	5.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	1.06e-05	5.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.06e-05	5.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TH—epilepsy syndrome	1.06e-05	5.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.05e-05	5.74e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.05e-05	5.74e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	1.05e-05	5.74e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.05e-05	5.72e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ABCB1—epilepsy syndrome	1.04e-05	5.69e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	1.04e-05	5.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.03e-05	5.62e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.03e-05	5.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	1.02e-05	5.56e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.02e-05	5.55e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	5.53e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	1.01e-05	5.52e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	1.01e-05	5.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	9.99e-06	5.45e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	9.97e-06	5.43e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	9.97e-06	5.43e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	9.96e-06	5.43e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.95e-06	5.43e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	9.93e-06	5.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	9.93e-06	5.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	9.92e-06	5.41e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	9.86e-06	5.38e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	9.84e-06	5.36e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AGT—epilepsy syndrome	9.8e-06	5.34e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	9.78e-06	5.33e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	9.77e-06	5.33e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	9.77e-06	5.33e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	9.76e-06	5.32e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	9.73e-06	5.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GPX1—epilepsy syndrome	9.7e-06	5.29e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	9.69e-06	5.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	9.66e-06	5.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	9.66e-06	5.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	9.66e-06	5.27e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	9.65e-06	5.26e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—APOE—epilepsy syndrome	9.6e-06	5.23e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	9.59e-06	5.23e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	9.59e-06	5.23e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	9.57e-06	5.22e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	9.56e-06	5.21e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	9.53e-06	5.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	9.42e-06	5.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	9.41e-06	5.13e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	9.36e-06	5.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	9.33e-06	5.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	9.31e-06	5.08e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SRC—epilepsy syndrome	9.26e-06	5.05e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—POMC—epilepsy syndrome	9.24e-06	5.04e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	9.12e-06	4.97e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	9.09e-06	4.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	9.08e-06	4.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	9.08e-06	4.95e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	9.07e-06	4.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	9.04e-06	4.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	9.02e-06	4.92e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	9.01e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	9.01e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	9e-06	4.91e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	8.92e-06	4.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	8.91e-06	4.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	8.91e-06	4.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	8.88e-06	4.84e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	8.87e-06	4.84e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	8.86e-06	4.83e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	8.84e-06	4.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	8.83e-06	4.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	8.82e-06	4.81e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	8.76e-06	4.78e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	8.73e-06	4.76e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CAT—epilepsy syndrome	8.72e-06	4.75e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	8.71e-06	4.75e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	8.71e-06	4.75e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	8.7e-06	4.74e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	8.67e-06	4.73e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	8.53e-06	4.65e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	8.52e-06	4.65e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AGT—epilepsy syndrome	8.51e-06	4.64e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	8.48e-06	4.62e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	8.44e-06	4.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	8.43e-06	4.6e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ALB—epilepsy syndrome	8.43e-06	4.59e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	8.42e-06	4.59e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOE—epilepsy syndrome	8.34e-06	4.55e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	8.33e-06	4.54e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	8.29e-06	4.52e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	8.29e-06	4.52e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	8.26e-06	4.5e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—POMC—epilepsy syndrome	8.25e-06	4.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	8.24e-06	4.49e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	8.24e-06	4.49e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	8.23e-06	4.49e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	8.2e-06	4.47e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	8.16e-06	4.45e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	8.14e-06	4.44e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	8.1e-06	4.42e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	8.09e-06	4.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	8.06e-06	4.39e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	8.03e-06	4.38e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	7.97e-06	4.34e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	7.93e-06	4.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GPX1—epilepsy syndrome	7.88e-06	4.3e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	7.88e-06	4.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	7.88e-06	4.29e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	7.66e-06	4.18e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	7.65e-06	4.17e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	7.63e-06	4.16e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	7.62e-06	4.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	7.58e-06	4.13e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	7.58e-06	4.13e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	7.56e-06	4.12e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	7.53e-06	4.11e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	7.52e-06	4.1e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ALB—epilepsy syndrome	7.52e-06	4.1e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	7.5e-06	4.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	7.46e-06	4.07e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	7.45e-06	4.06e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTGS2—epilepsy syndrome	7.37e-06	4.02e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	7.37e-06	4.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	7.32e-06	3.99e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	7.31e-06	3.99e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	7.24e-06	3.95e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	7.22e-06	3.94e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	7.22e-06	3.94e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	7.21e-06	3.93e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—POMC—epilepsy syndrome	7.16e-06	3.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	7.12e-06	3.88e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	7.12e-06	3.88e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	7.08e-06	3.86e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	7.04e-06	3.84e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	7.01e-06	3.82e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	6.97e-06	3.8e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.96e-06	3.8e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	6.95e-06	3.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	6.92e-06	3.77e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	6.92e-06	3.77e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AGT—epilepsy syndrome	6.91e-06	3.77e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	6.89e-06	3.75e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	6.83e-06	3.72e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—epilepsy syndrome	6.77e-06	3.69e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	6.73e-06	3.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	6.71e-06	3.66e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	6.7e-06	3.65e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	6.7e-06	3.65e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—epilepsy syndrome	6.58e-06	3.59e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	6.57e-06	3.58e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	6.56e-06	3.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.55e-06	3.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ALB—epilepsy syndrome	6.53e-06	3.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.47e-06	3.53e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	6.41e-06	3.5e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	6.4e-06	3.49e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	6.33e-06	3.45e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	6.27e-06	3.42e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	6.23e-06	3.4e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	6.22e-06	3.39e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	6.22e-06	3.39e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	6.19e-06	3.38e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	6.09e-06	3.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	6.09e-06	3.32e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	5.99e-06	3.27e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	5.97e-06	3.26e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	5.86e-06	3.19e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.82e-06	3.17e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.79e-06	3.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.78e-06	3.15e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	5.75e-06	3.14e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	5.75e-06	3.13e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	5.72e-06	3.12e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	5.71e-06	3.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.67e-06	3.09e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	5.66e-06	3.09e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	5.6e-06	3.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	5.55e-06	3.02e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	5.34e-06	2.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	5.32e-06	2.9e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ALB—epilepsy syndrome	5.3e-06	2.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	5.3e-06	2.89e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	5.26e-06	2.87e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	5.24e-06	2.85e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	5.2e-06	2.83e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	5.16e-06	2.81e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	5.12e-06	2.79e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.1e-06	2.78e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	4.92e-06	2.68e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.86e-06	2.65e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	4.82e-06	2.63e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.79e-06	2.61e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.76e-06	2.6e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.75e-06	2.59e-05	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.73e-06	2.58e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	4.69e-06	2.56e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.64e-06	2.53e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	4.63e-06	2.52e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	4.61e-06	2.51e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	4.55e-06	2.48e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.49e-06	2.45e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.48e-06	2.44e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	4.43e-06	2.42e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.43e-06	2.41e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.35e-06	2.37e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	4.31e-06	2.35e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	4.3e-06	2.35e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	4.3e-06	2.34e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.3e-06	2.34e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	4.21e-06	2.3e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	4.19e-06	2.28e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	4.14e-06	2.25e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.08e-06	2.23e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	4.06e-06	2.22e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.03e-06	2.2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.99e-06	2.18e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	3.98e-06	2.17e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.92e-06	2.14e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.91e-06	2.13e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.88e-06	2.11e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.86e-06	2.11e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	3.77e-06	2.05e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.76e-06	2.05e-05	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AKT1—epilepsy syndrome	3.71e-06	2.02e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	3.66e-06	2e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.64e-06	1.98e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.6e-06	1.96e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.55e-06	1.94e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.5e-06	1.91e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.4e-06	1.86e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	3.38e-06	1.84e-05	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AKT1—epilepsy syndrome	3.31e-06	1.8e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.3e-06	1.8e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.29e-06	1.79e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.14e-06	1.71e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.06e-06	1.67e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.87e-06	1.57e-05	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.57e-06	1.4e-05	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.54e-06	1.38e-05	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.4e-06	1.31e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.33e-06	1.27e-05	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.1e-06	1.14e-05	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.95e-06	1.06e-05	CbGpPWpGaD
